(Q34556167)

3 August 2017

1 reference

title

Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines (English)

1 reference

3 August 2017

0 references

4

Aaby P

1 reference

3 August 2017

Roth AE

1

1 reference

PubMed ID

16901755

3 August 2017

Stensballe LG

series ordinal

2

1 reference

PubMed ID

16901755

3 August 2017

Garly ML

series ordinal

3

1 reference

3 August 2017

8 August 2006

1 reference

3 August 2017

1 reference

3 August 2017

86

1 reference

3 August 2017

397-403

1 reference

3 August 2017

6

1 reference

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Influence of Mycobacterium bovis Bacillus Calmette-Guerin on Antibody and Cytokine Responses to Human Neonatal Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Does childhood immunization against infectious diseases protect from the development of atopic disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

The inverse association between tuberculin responses and atopic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Age at bacille Calmette-Guerin vaccination and risk of allergy and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross-sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

BCG vaccination and risk of atopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Routine vaccinations and child survival in a war situation with high mortality: effect of gender

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Risk factors for death caused by pneumonia in children younger than 1 year old in a metropolitan region of southeastern Brazil. A case- control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Childhood mortality among users and non-users of primary health care in a rural west African community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000–2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

BCG vaccination scar associated with better childhood survival in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Child mortality following standard, medium or high titre measles immunization in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

The success and failure of BCG - implications for a novel tuberculosis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Early BCG vaccination and reduction in atopy in Guinea-Bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Lower Hookworm Incidence, Prevalence, and Intensity of Infection in Children with a Bacillus Calmette‐Guérin Vaccination Scar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Patterns of helminth infection and relationship to BCG vaccination in Karonga District, northern Malawi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Protective efficacy of BCG against leprosy in Northern Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.02.001

10.1016/J.TUBE.2006.02.001

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

16901755